Department of Cell Biology & Guangdong Provincial Key Laboratory of Bioengineering Medicine, Jinan University, Guangzhou, China.
Department of Pharmacology, Jinan University, Guangzhou, China.
J Cell Mol Med. 2021 Apr;25(8):3950-3962. doi: 10.1111/jcmm.16347. Epub 2021 Feb 19.
Self-renewal and differentiation of spermatogonial stem cell (SSC) are critical for male fertility and reproduction, both of which are highly regulated by testicular microenvironment. Exosomal miRNAs have emerged as new components in intercellular communication. However, their roles in the differentiation of SSC remain unclear. Here, we observed miR-486-5p enriched in Sertoli cell and Sertoli cell-derived exosomes. The exosomes mediate the transfer of miR-486-5p from Sertoli cells to SSCs. Exosomes release miR-486-5p, thus up-regulate expression of Stra8 (stimulated by retinoic acid 8) and promote differentiation of SSC. And PTEN was identified as a target of miR-486-5p. Overexpression of miR-486-5p in SSCs down-regulates PTEN expression, which up-regulates the expression of STRA8 and SYCP3, promotes SSCs differentiation. In addition, blocking the exosome-mediated transfer of miR-486-5p inhibits differentiation of SSC. Our findings demonstrate that miR-486-5p acts as a communication molecule between Sertoli cells and SSCs in modulating differentiation of SSCs. This provides a new insight on molecular mechanisms that regulates SSC differentiation and a basis for the diagnosis, treatment, and prevention of male infertility.
精原干细胞(SSC)的自我更新和分化对于雄性生育和繁殖至关重要,而这两者都受到睾丸微环境的高度调节。外泌体 miRNAs 已成为细胞间通讯的新成分。然而,它们在 SSC 分化中的作用尚不清楚。在这里,我们观察到 miR-486-5p 在支持细胞和支持细胞衍生的外泌体中富集。外泌体介导 miR-486-5p 从支持细胞到 SSC 的转移。外泌体释放 miR-486-5p,从而上调 Stra8(维甲酸 8 刺激)的表达并促进 SSC 的分化。并且鉴定出 PTEN 是 miR-486-5p 的靶标。SSC 中转录上调 miR-486-5p 下调 PTEN 表达,上调 STRA8 和 SYCP3 的表达,促进 SSCs 分化。此外,阻断 miR-486-5p 的外泌体介导转移抑制 SSC 的分化。我们的研究结果表明,miR-486-5p 在调节 SSC 分化中作为支持细胞和 SSC 之间的通讯分子发挥作用。这为调控 SSC 分化的分子机制提供了新的见解,并为男性不育的诊断、治疗和预防提供了依据。
Cell Biochem Funct. 2017-4
Reprod Biol Endocrinol. 2021-6-9
Front Neurol. 2025-7-23
Bioimpacts. 2025-7-1
Front Endocrinol (Lausanne). 2025-6-4
Reprod Biol Endocrinol. 2025-5-21
Adv Exp Med Biol. 2025
Mol Ther Nucleic Acids. 2024-10-28
J Dev Biol. 2024-8-23
Stem Cell Res Ther. 2024-9-11
Front Bioeng Biotechnol. 2020-4-8
Mol Biol Rep. 2018-12